Effects of Alternate Nostril Breathing Versus Diaphragmatic Breathing on Oxygen Saturation and Heart-rate Variability in Post Percutaneous Coronary Intervention Patients

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age44-75
SponsorFoundation University Islamabad

About this trial

This study is a two-arm randomized parallel group trial designed to compare the effects of alternate nostril breathing vs diaphragmatic breathing on oxygen saturation and Heart-rate variability in hemodynamically stable post-PCI patients. Participants will be randomly allocated in a 1:1 ratio to alternate nostril breathing or diaphragmatic breathing and will receive the allocated intervention for 2 consecutive days with three supervised sessions per day in addition to routine post-PCI care. Oxygen saturation will be assessed using a pulse oximeter and heart-rate variability will be assessed using a Polar H10 sensor at baseline and after the intervention. The study will determine whether there is a difference between two breathing interventions in the prescribed outcome measures.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Adults aged 44-75 years

Hemodynamically stable post-PCI patients with systolic blood pressure>90 mmHg, diastolic BP 50-100mmHg Heart-rate 60-100 beats/min and no ongoing chest pain or signs of acute clinical instability.

Oxygen saturation >92% on room air

Able to follow simple verbal instructions and perform the breathing exercises.

Disqualifiers

Ongoing myocardial ischemia, unstable angina, significant arrythmia or requirement for inotropic/vasopressor support.

Cardiogenic shock or severe heart failure (NYHA class IV)

Recent thoracic surgery or chest wall injury limiting rib expansion or deep breathing.

Cardiac implantable electronic device (pacemaker/ICD) with pacing dependency or an implanted ventricular assist device.

Trial design

Design model

Parallel

Treatments tested in this trial

  • Alternate Nostril Breathing

    Behavioral

    Non-pharmacological breathing interventions administered under physiotherapist supervision for 2 consecutive days with three sessions per day in addition to routine post-PCI care.

  • Diaphragmatic breathing

    Other intervention

    Participants assigned to this group will perform diaphragmatic breathing under physiotherapist supervision in addition to routine post-PCI care. The participant will lie supine or sit upright with the back supported, with one hand on the upper chest and the other on the abdomen below the rib cage. The participant will inhale slowly through the nose while allowing the abdomen to rise and then exhale slowly through pursed lips while allowing the abdomen to fall. Post-PCI Day 0 : 3 sessions/day approximately 15mins/session,10 repetitions. Post-PCI Day 1 :3 supervised sessions/day approximately 20 minutes/session, 15 repetitions.

Treatment groups

36 Participants
are divided into 2 treatment groups
Group A: Alternate Nostril breathing Group AExperimental treatment 1 intervention
Group B: Diaphragmatic breathing Group BActive comparator 1 intervention

Trial outcomes

Primary outcomes

1

Change in Oxygen saturation

Change in peripheral oxygen saturation (SpO₂) from baseline to the specified post-intervention assessment time point, measured using a pulse oximeter. Oxygen saturation will be recorded as a percentage (%) and compared between baseline and post-intervention measurements.

Time frame
Baseline and immediately after completion of the 2-day intervention period.
2

Change in Heart Rate Variability (HRV)

Change in heart rate variability from baseline to the specified post-intervention assessment time point, assessed using a validated heart rate/ECG monitoring device. Heart rate variability will be evaluated using predefined HRV parameters, such as time-domain and/or frequency-domain measures, as applicable to the study protocol.

Time frame
Baseline and immediately after completion of the 2-day intervention period.

Secondary outcomes

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.